Chemopreventive effect of natural dietary compounds on xenobiotic-induced toxicity

Jia-Ching Wu1, Ching-Shu Lai2, Mei-Ling Tsai2

  • 1Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan.

Insights

Natural dietary compounds from foods and plants can prevent harmful contaminant effects. These compounds aid in metabolizing and excreting toxins, reducing toxicity and cancer risk.

Area of Science:

  • Environmental Health
  • Nutritional Science
  • Toxicology

Background:

  • Human health is increasingly impacted by environmental contaminants.
  • Natural dietary compounds show promise in mitigating contaminant-induced harm.
  • Chemically-induced carcinogenesis is linked to reactive metabolites and disrupted biological functions.

Purpose of the Study:

  • To review natural dietary compounds from foods and plants.
  • To explore their mechanisms in preventing contaminant-induced toxicity.
  • To summarize their role in suppressing contaminant-induced carcinogenesis.

Main Methods:

  • Literature review of studies on natural dietary compounds.
  • Analysis of mechanisms involving metabolic regulation of hazardous chemicals.
  • Investigation of Phase I and II metabolizing enzyme induction for contaminant excretion.

Main Results:

  • Natural compounds exhibit beneficial effects against disease and carcinogenesis.
  • Metabolic regulation is crucial for reducing adverse health effects from contaminants.
  • Promoting contaminant excretion via metabolizing enzymes is a viable protective strategy.

Conclusions:

  • Natural dietary compounds offer a promising approach to counteract contaminant toxicity.
  • Understanding these compounds' mechanisms can lead to preventative health strategies.
  • Dietary interventions may play a significant role in mitigating environmental health risks.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
36
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
31
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
20
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
48
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
2.3K